These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 35912717)

  • 1. Correlation of vascular and fluid-related parameters in neovascular age-related macular degeneration using deep learning.
    Schranz M; Told R; Hacker V; Reiter GS; Reumueller A; Vogl WD; Bogunovic H; Sacu S; Schmidt-Erfurth U; Roberts PK
    Acta Ophthalmol; 2023 Feb; 101(1):e95-e105. PubMed ID: 35912717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OCTA Biomarker Search in Patients with nAMD: Influence of Retinal Fluid on Time-Dependent Biomarker Response.
    Told R; Reumueller A; Schranz M; Brugger J; Weigert G; Reiter GS; Sacu S; Schmidt-Erfurth U
    Curr Eye Res; 2023 Jun; 48(6):600-604. PubMed ID: 36891909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of Retinal Thickness and Swept-Source Optical Coherence Tomography Angiography Derived Vascular Changes in Patients with Neovascular Age-Related Macular Degeneration.
    Told R; Reiter GS; Schranz M; Reumueller A; Hacker V; Mittermueller TJ; Roberts PK; Sacu S; Schmidt-Erfurth U
    Curr Eye Res; 2021 Jul; 46(7):1002-1009. PubMed ID: 33211556
    [No Abstract]   [Full Text] [Related]  

  • 4. Artificial intelligence-based fluid quantification and associated visual outcomes in a real-world, multicentre neovascular age-related macular degeneration national database.
    Martin-Pinardel R; Izquierdo-Serra J; De Zanet S; Parrado-Carrillo A; Garay-Aramburu G; Puzo M; Arruabarrena C; Sararols L; Abraldes M; Broc L; Escobar-Barranco JJ; Figueroa M; Zapata MA; Ruiz-Moreno JM; Moll-Udina A; Bernal-Morales C; Alforja S; Figueras-Roca M; Gómez-Baldó L; Ciller C; Apostolopoulos S; Mosinska A; Casaroli Marano RP; Zarranz-Ventura J;
    Br J Ophthalmol; 2024 Jan; 108(2):253-262. PubMed ID: 36627173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative response of macular neovascularisation to loading phase of aflibercept in neovascular age-related macular degeneration.
    Montesel A; Hagag AM; Chandra S; Muhammed RP; Thottarath S; Chandak S; Sivaprasad S
    Eye (Lond); 2023 Dec; 37(17):3648-3655. PubMed ID: 37258659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EFFECT OF RANIBIZUMAB AND AFLIBERCEPT ON RETINAL PIGMENT EPITHELIAL DETACHEMENT, SUBRETINAL AND INTRARETINAL FLUID IN AGE-RELATED MACULAR DEGENERATION.
    Sumarová P; Ovesná P; Matušková V; Beránek J; Michalec M; Michalcová L; Autrata D; Vysloužilová D; Chrapek O
    Cesk Slov Oftalmol; 2022; 78(4):176-185. PubMed ID: 35922146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of sub-retinal fluid in determining treatment outcomes in patients with neovascular age-related macular degeneration--a phase IV randomised clinical trial with ranibizumab: the FLUID study.
    Arnold JJ; Markey CM; Kurstjens NP; Guymer RH
    BMC Ophthalmol; 2016 Mar; 16():31. PubMed ID: 27009515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of retinal alterations with vascular structure of macular neovascularisation in swept-source optical coherence tomography angiography in age-related macular degeneration.
    Faatz H; Rothaus K; Ziegler M; Book M; Spital G; Heimes-Bussmann B; Pauleikhoff D; Lommatzsch A
    Int Ophthalmol; 2022 May; 42(5):1553-1562. PubMed ID: 35028773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of retinal fluid monitoring in OCT imaging by automated deep learning versus human expert grading in neovascular AMD.
    Pawloff M; Gerendas BS; Deak G; Bogunovic H; Gruber A; Schmidt-Erfurth U
    Eye (Lond); 2023 Dec; 37(18):3793-3800. PubMed ID: 37311835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profiling neovascular age-related macular degeneration choroidal neovascularization lesion response to anti-vascular endothelial growth factor therapy using SSOCTA.
    Told R; Reiter GS; Mittermüller TJ; Schranz M; Reumueller A; Schlanitz FG; Weigert G; Pollreisz A; Sacu S; Schmidt-Erfurth U
    Acta Ophthalmol; 2021 Mar; 99(2):e240-e246. PubMed ID: 32706171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognosis criteria of optical coherence tomography angiography for the long-term efficacy of anti-VEGF therapy of neovascular age-related macular degeneration].
    Fursova AZ; Nikulich IF; Dmitrieva EI; Gusarevich OG; Derbeneva AS; Vasilyeva MA; Kozhevnikova OS; Kolosova NG; Rabota FK
    Vestn Oftalmol; 2023; 139(6):50-58. PubMed ID: 38235630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analyses of the effects of persistent subretinal fluid on visual/anatomic outcomes according to the type of macular neovascularization during the relaxed treat-and-extend protocol in age-related macular degeneration patients.
    Kim KT; Chae JB; Lee S; Seo EJ; Kim DY
    BMC Ophthalmol; 2021 Aug; 21(1):294. PubMed ID: 34376158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Choroidal Neovascularization and Haller Vessel Morphology Associated with Vision and Treatment Number after 1 Year in Age-related Macular Degeneration.
    Kim S; Lee H; Chung H; Kim HC
    Korean J Ophthalmol; 2021 Oct; 35(5):397-409. PubMed ID: 34344131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of 3-Dimensionally Quantified Intraretinal and Subretinal Fluid With Visual Acuity in Neovascular Age-Related Macular Degeneration.
    Waldstein SM; Philip AM; Leitner R; Simader C; Langs G; Gerendas BS; Schmidt-Erfurth U
    JAMA Ophthalmol; 2016 Feb; 134(2):182-90. PubMed ID: 26661463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Automated Quantitative Assessment of Retinal Fluid Volumes as Important Biomarkers in Neovascular Age-Related Macular Degeneration.
    Keenan TDL; Chakravarthy U; Loewenstein A; Chew EY; Schmidt-Erfurth U
    Am J Ophthalmol; 2021 Apr; 224():267-281. PubMed ID: 33359681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utilization of deep learning to quantify fluid volume of neovascular age-related macular degeneration patients based on swept-source OCT imaging: The ONTARIO study.
    Sodhi SK; Pereira A; Oakley JD; Golding J; Trimboli C; Russakoff DB; Choudhry N
    PLoS One; 2022; 17(2):e0262111. PubMed ID: 35157713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optical coherence tomography angiography biomarkers in a bi-monthly maintenance dosing aflibercept in patients with neovascular age-related macular degeneration.
    Park JB; Kim K; Kang MS; Kim ES; Yu SY
    BMC Ophthalmol; 2023 Jul; 23(1):314. PubMed ID: 37438681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic response in the HAWK and HARRIER trials using deep learning in retinal fluid volume and compartment analysis.
    Schmidt-Erfurth U; Mulyukov Z; Gerendas BS; Reiter GS; Lorand D; Weissgerber G; Bogunović H
    Eye (Lond); 2023 Apr; 37(6):1160-1169. PubMed ID: 35523860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive role of optical coherence tomography angiography for exudation recurrence in patients with type 1 neovascular age-related macular degeneration treated with pro-re-nata protocol.
    Choi M; Kim SW; Yun C; Oh JH; Oh J
    Eye (Lond); 2023 Jan; 37(1):34-41. PubMed ID: 34992249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Intra- and Subretinal Fluid on Vision Based on Volume Quantification in the HARBOR Trial.
    Riedl S; Vogl WD; Waldstein SM; Schmidt-Erfurth U; Bogunović H
    Ophthalmol Retina; 2022 Apr; 6(4):291-297. PubMed ID: 34922038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.